Login / Signup

[Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis].

O N KotenkoL V AbolyanV I KuteinikovV E VinogradovV V Fomin
Published in: Terapevticheskii arkhiv (2023)
HRQOL assessment is important tool for planning and evaluating the effectiveness of anemia drug therapy among patients with CKD on hemodialysis.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • peritoneal dialysis
  • randomized controlled trial
  • systematic review
  • acute kidney injury
  • emergency department
  • ejection fraction
  • iron deficiency
  • adverse drug